Pfizer (NYSE:PFE) - Page 2

stock symbol ticker

The 4 Stocks That Boosted the Market

September 17, 2014: Markets opened slightly mixed on Wednesday and traded in a narrow range around the break-even line until the FOMC meeting announcement in mid-afternoon. The word that interest ...
Read Full Story »
stock symbol ticker

The 4 Stocks That Shored Up the Dow

September 15, 2014: Markets opened slightly lower on Monday after the OECD lowered its U.S. GDP growth forecast. The Empire State manufacturing index rose sharply in September. That rise was ...
Read Full Story »
Stock Split Image

Key Short Interest Changes in Defensive High-Yield Dividend Stocks

The short interest data for the August 29 settlement date is out, and we have decided to look at what is happening in the short interest of the go-to high-dividend ...
Read Full Story »
Facebook-F-logo

Facebook More Valuable Than IBM

A great deal was made of the value of Facebook Inc. (NASDAQ: FB) as it crossed the $200 billion market cap level. As a sign of just how meaningful the ...
Read Full Story »
dividends

Short Interest Swings in High-Yield Dividend Stocks

The short interest data are out for the August 15 settlement date. 24/7 Wall St. reviews the higher-yield defensive dividend stocks for a sense of what short sellers may be ...
Read Full Story »
stock symbol ticker

The 4 Stocks That Pushed the DJIA and S&P 500 to New Highs

August 26, 2014: Markets opened higher on Tuesday following a huge jump in durable goods orders, a better-than-expected report on consumer confidence, and a slowdown in home price increases. The ...
Read Full Story »
health care

ELIQUIS Approved for Deep Vein Thrombosis and Pulmonary Embolisms

Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) had approved the drug ELIQUIS, as a treatment for Deep Vein Thrombosis and Pulmonary ...
Read Full Story »
Stock Split Image

3 DJIA Stocks at Real Risk of Hitting 52-Week Lows

Investors seem to have grown accustomed to seeing the Dow Jones Industrial Average (DJIA) hitting new high after new high in 2014. Only the recent market volatility has created a ...
Read Full Story »
stock symbol ticker

The 4 Stocks That Carried the Market

August 14, 2014: Markets opened higher on Thursday after a slightly worse-than-expected report on new claims for unemployment benefits.  U.S. export prices were higher in July and natural gas prices ...
Read Full Story »
stock symbol ticker

The 4 Stocks That Weighed on the Market

August 12, 2014: Markets opened lower on Tuesday, took a brief turn into the green, and then settled into the red by mid-morning. Energy stocks led the decline as data ...
Read Full Story »
Stock Split Image

Key Short Interest Changes in Defensive High-Yield Dividend Stocks

The short interest data is out for the July 31 settlement date. We often review the higher-yield defensive dividend stocks for a barometer of what short sellers may be thinking. ...
Read Full Story »
buy sell

Top Analyst Upgrades and Downgrades: Groupon, Micron, RingCentral, Target, Tesla, Monster, Pfizer and More

Stocks fell again on Tuesday, and Wednesday's indications are lower as well. Investors still want upside, but they are also getting more selective on stocks versus the stock market in ...
Read Full Story »
Pfizer logo

Jefferies Picks Top Franchise Stocks to Buy

All of the top Wall Street firms that we cover here at 24/7 Wall St. have a list of what are truly their premium stocks to buy for their customers. ...
Read Full Story »
stock symbol ticker

The 4 Stocks That Sank the DJIA

July 29, 2014: Markets opened higher on Tuesday following a modestly better showing from companies reporting earnings before the opening bell. There was no major economic news today and everyone ...
Read Full Story »
O.M.G-viagra-image

Sears.com Sold Erectile Treatment With Viagra Ingredients

A purported herbal sexual health supplement called O.M.G. has been found by the U.S. Food and Drug Administration (FDA) to contain generic sildenafil, the active ingredient in Pfizer Inc.'s (NYSE: ...
Read Full Story »